from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2760c/vapB42

LFCtreatmentdescriptionclass of inhibitor

0.336

Amikacinug/mL Amikacintranslation

0.105

Cap5-10ug/mL Capreomycintranslation

0.729

Rox10-50 ug/mL Roxithromycintranslation

0.560

SM2-5 ug/mL Streptomycintranslation

2.250

Tet5-10 ug/mL Tetracyclinetranslation

1.278

Rif0.2-5ug/mL Rifampicintranscription

0.440

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.727

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.696

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.357

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.308

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.509

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.591

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.581

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.510

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.668

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.027

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.200

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.152

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.198

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.005

KCN5-20 ug/mL Potassium cyaniderespiration

-0.032

NaN30.2-2 mM Sodium aziderespiration

0.120

Nigericin50 uM Nigericinrespiration

0.411

TRC10-150 ug/mL Triclosanrespiration

0.496

TRZ10-25 ug/mL Thioridazinerespiration

1.242

Valinomycin0.5-10 uM Valinomycinrespiration

0.425

ZnSO42 mM ZnSO4respiration

0.263

menadione6-10 ug/mL Menadionerespiration

-0.208

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.637

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.374

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.223

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.469

NRP_1Non-replicating persistence stage 1dosRassociated

-0.944

Amp0.2mg/mL AmpicillincellWall

0.358

Cephalexin20-100 ug/mL CephalexincellWall

-0.603

Cerulenin0.32-5 ug/mL CerulenincellWall

0.097

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.131

EMB10-20 ug/mL EthambutolcellWall

0.029

Eta12-40 ug/mL EthionamidecellWall

-0.231

INH0.2-0.4 ug/mL IsoniazidcellWall

0.232

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.190

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.057

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.067

BZA0.12 mg/mL BenzamidearomaticAmides

0.240

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.028

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.291

H2O24 mM hydrogen peroxideDNAdamaging

-0.054

Levo10 ug/mL LevofloxacinDNAdamaging

0.208

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.022

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.415

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.825

UVUV-irradiationDNAdamaging

0.996

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.665

Antimycin12.5-50 ug/mL Antimycin A?

0.363

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.072

PA_110-50 ug/mL Antitubercular compound PA-1?

0.456

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.449

PA8240.2-2 ug/mL PA-824?

-0.510

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.668

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.222

Verapamil50 uM Verapamil?

0.748

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.350

methoxatin10-20 ug/mL Methoxatin?